CDC revealed nationally representative estimates of chronic fatigue; the proposed merger between Cigna and Humana has been terminated over financial terms and shareholder skepticism; ChatGPT provides inaccurate responses to medication queries.
The CDC has unveiled the first nationally representative estimate of US adults living with chronic fatigue syndrome, totaling 3.3 million individuals, according to the Associated Press. The number, larger than previously thought, includes patients with long COVID, shedding light on the condition's prevalence. The report challenges stereotypes, revealing that chronic fatigue is not confined to a specific demographic, as both men and women across various racial and economic groups report its debilitating effects, emphasizing the need for increased awareness and understanding.
Cigna has halted its pursuit of a $140 billion merger with competitor Humana following unsuccessful negotiations and shareholder apprehensions, as reported by The Wall Street Journal. Shareholders expressed reservations about the proposed cash-and-stock transaction, causing a nearly 10% drop in Cigna's stock. While Cigna remains supportive of the potential benefits of a merged entity, the company now shifts its focus to smaller acquisitions and plans $10 billion in stock buybacks.
A study conducted by researchers at Long Island University has uncovered limitations in the ability of ChatGPT, an artificial intelligence (AI) chatbot, to address medical queries accurately, according to CNN. The research, presented at the annual meeting of the American Society of Health-System Pharmacists, compared the chatbot's responses to 39 medication-related questions against those from trained pharmacists and found that only about 10 questions received accurate responses. Furthermore, the study revealed that ChatGPT provided fabricated references for some responses, raising concerns about potential risks and emphasizing the importance of relying on professional medical advice rather than AI for health-related concerns.
Enhancing Outpatient Hemophilia Care May Improve Health Outcomes and Costs
May 18th 2024Prospective data from patients attending a rural practice in West Virginia between 2016 and 2023 show that a quality improvement program that followed guideline recommendations and was tailored to specific patient needs reduced preventable bleeds and lowered costs.
Read More
Health Equity and Access Weekly Roundup: May 18, 2024
May 18th 2024The US Senate hosted a panel addressing physician and health care shortages and efforts to increase minority representation in the medical field. An expert discussed initiatives to prevent senior homelessness. Advocates called for the repeal of the Comstock Act. Regulatory reforms are called for to improve rural cancer patients' access to pharmacies. Research reveals the impact of denials on patient access to immunology treatments.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Congress Urged to Repeal Comstock Act Threatening Reproductive Rights and Public Health
May 16th 2024In a joint letter addressed to Congress, Healthcare Across Borders, Take Back the Court Action Fund, and UltraViolet Action called out the resurgence of the Comstock Act, urging immediate action to repeal this century-old law that threatens reproductive rights and public health in the US.
Read More
After the ACA Expanded Health Care Access, 2024 Elections May See Voters Demand Affordability
May 15th 2024At the spring conference of the New Jersey Health Care Quality Institute, speakers discussed how health policy, affordability, and transparency may play a role in voters’ decisions.
Read More